As of 2026-04-05, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -6.57 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 15.2x | 14.3x |
| Forward P/E multiples | 15.7x - 20.1x | 18.0x |
| Fair Price | (1,055.14) - (1,023.32) | (1,089.38) |
| Upside | -4397.9% - -4268.3% | -4537.4% |
| Date | EV/EBITDA |